Scientific Programme
September 12th, 2010 - Sunday
Main Foyer & Exhibition Area
18.00-19.30
Opening Ceremony
Welcome Reception
September 13th, 2010 - Monday
Auditorium
COUNTING THE CASES AND THE COST: GLAUCOMA Epidemiology/ Screening/ Health Economics
8.30-8.50
Welcome
C. Migdal (United Kingdom), R. A. Hitchings (United Kingdom), C. E. Traverso (Italy) – European Glaucoma Society
K. Singh (USA) - World Glaucoma Association
8.50-9.10
Keynote Lecture
Epidemiology of various forms of glaucoma in Europe: impact on the approach to glaucoma treatment
D. S. Friedman (USA)
9.10-10.00
Main Session: RISKY BUSINESS: risk factors in glaucoma
Chairs: C. Migdal (United Kingdom), N. Pfeiffer (Germany)
- Clinical implications of risk factor assessment in different types of glaucoma
S. Miglior (Italy) - Risk factors for glaucoma prevalence, incidence and progression?
A. L. Coleman (USA) - Are there differences in risk factors for POAG, PEXG and ACG?
G. Gazzard (United Kingdom)
How is eye disease /glaucoma supported in the EU?
A. Buyse (Belgium) General Representative of the Flemish Government to the EU
(Organizer: T. Zeyen)
10.00-10.30
Break
10.30-11.40
Main Session: COST AND QUALITY: Health Economics / Quality of life
Chairs: A. Azuara-Blanco (United Kingdom) A. Tuulonen (Finland)
- Where to put the money: glaucoma screening and glaucoma management ('shared care')
P. Spry (United Kingdom) - Improving cost effectiveness in glaucoma case finding
A. Tuulonen (Finland) - Counting the cost of glaucoma treatment; medical versus laser versus surgical treatment
S. Gandolfi (Italy) - Glaucoma quality of live - how can prevention help?
D. Crabb (United Kingdom)
11.40-12.20
FREE PAPERS 2 (selected from the abstracts)
INTRAOCULAR PRESSURE – BIOMECHANICS – GENETICS – NEUROPROTECTION – BLOOD FLOW
Chairs: C. O’Brien (Ireland) F. Topouzis (Greece)
- FP2.1
Genome-wide association study of normal tension glaucoma in the Japanese population
A. Meguro, M. Ota, S. Ohno, H. Inoko, N. Mizuki (Japan) - FP2.2
Proteolytic cleavage of the chemokine CXCL12/SDF-1 controls trabecular cell death
A. Denoyer, D. Godefroy, F. Baudouin, W. Rostene, C. Baudouin (France) - FP2.3
Three dimensional histomorphometry of the normal and early experimental glaucomatous (EEG) rat optic nerve head
M. Pazos, S. Gardiner, J. Reynaud, J. Grimm, W.O. Cepurna, E.C. Johnson, J.C. Morrison, C.F. Burgoyne, H. Yang (Spain, USA) - FP2.4
Systemic blood pressure and incidence of primary open angle glaucoma in the prospective study alienor
C. Schweitzer, J. Colin , F. Malet, M.-B. Rougier, M.-N. Delyfer, M. Legoff, J.-F. Dartigues, P. Barberger-Gateau, J.-F. Korobelnik, C. Delcourt (France), J.H. Kim, N.R. Kim, E.S. Lee, C.Y. Kim, K.T. Ma (Korea) - FP2.5
Retrobulbar haemodynamics in various types of glaucoma
F. Galassi, B. Giambene (Italy)
Santen Lunch Symposium
Glaucoma - the path to the future
Chair: R.A. Hitchings (United Kingdom)
- Prostaglandins and ocular surface disease
C. Baudouin (France) - Compliance in the medical management of glaucoma
A. Anton Lopez (Spain) - Preservative free prostaglandin – experiences in clinical use
L. E. Pillunat (Germany) - Diurnal IOP monitoring with an ocular telemetry sensor in patients on tafluprost treatment
T. Shaarawy (Switzerland) - Practical recommendations for measuring rates of visual field change in glaucoma
A. Heijl (Sweden) - Discussion
INSTRUCTIONAL COURSES - 1 (7 parallel)
Room 1 - Unesco
C1 - 48 Angle closure (basic)
J. Thygesen (Denmark), G. Gazzard (United Kingdom), T. Wong (Singapore)
Room 2
C1 - 32 Gonioscopy (basic)
J.F. Salmon (United Kingdom), Y. Lachkar (France)
Room 7
C1 - 19 + 20a Aqueous tube implantation (int/advanced)
K. Barton (United Kingdom), J. L. Brookes (United Kingdom), S. Duch (Spain), K. S. Lim (United Kingdom)
Room 8
C1 - 37 + 38a The visual field in glaucoma (advanced)
F.J. Goñi (Spain), D. Garway-Heath (United Kingdom), P. Brusini (Italy)
Room 9bis
C1 - 53 + 54a Disability from glaucoma (intermediate)
A.C. Viswanathan (United Kingdom), D. Crabb (United Kingdom), A. King (United Kingdom) A. Kotecha (United Kingdom)
Room Goya
C1 - 13 Trabeculectomy tricks (Int.)
C. Vass (Austria), F. Topouzis (Greece), F. Lerner (Argentina)
Room Privados
C1 - 18 Cataract surgery in glaucoma patients (basic)
C.E. Traverso (Italy), K.F. Tomey (Lebanon)
15.15-15.45
POSTER SESSION AT THE POSTER SITES
Epidemiology – Health Economics – Quality of Life
15:45-16:45
INSTRUCTIONAL COURSES - 2 (8 parallel)
Room 1 - Unesco
C2 - 8 Glaucoma surgery (basic/int)
F. Grehn (Germany), F. Lerner (Argentina)
Room 2
C2 - 22 Angle surgery: how to get rid of the bleb (int/advanced)
S. Gandolfi (Italy), R. Carassa (Italy), T. Klink (Germany)
Room 7
C2 - 19 + 20b Aqueous tube implantation (int/advanced)
K. Barton (United Kingdom), J. L. Brookes (United Kingdom), S. Duch (Spain), K.S. Lim (United Kingdom)
Room 8
C2 - 37 + 38b The visual field in glaucoma (advanced)
F.J. Goñi (Spain), D. Garway-Heath (United Kingdom), P. Brusini (Italy)
Room 9
C2 - 60 Ophthalmology - A philatelic vision
T. Zeyen (Belgium)
Room 9bis
C2 - 53 + 54b Disability from glaucoma (intermediate)
A.C. Viswanathan (United Kingdom), D. Crabb (United Kingdom), A. King (United Kingdom) A. Kotecha (United Kingdom)
Room Goya
C2 - 2 Trabecular meshwork changes in POAG (basic/int)
I. Grierson (United Kingdom), E. Tamm (Germany)
Room Privados
C2 - 46 EGS Guidelines (basic/int)
J. Thygesen (Denmark)
17.00-18.30
Pfizer Afternoon Symposium - Glaucoma: seeing the bigger picture
Chairs: N. Pfeiffer (Germany), T. Zeyen (Belgium)
- Welcome and Introduction
N. Pfeiffer (Germany) - A portrait of glaucoma: assessing the global burden
R. Varma (USA) - Expanding the clinical landscape: when should a glaucoma suspect be treated?
T. Zeyen (Belgium) - Selecting your treatment: drawing on the evidence
F. Topouzis (Greece) - Focusing on the individual: tailoring management strategies
N. Pfeiffer (Germany) - An outlook on advancing glaucoma: reflecting on the complexity of disease progression
R. Susanna (Brazil) - Question and Answers and close
September 14th, 2010 - Tuesday
Auditorium
BACK TO BASICS: Glaucoma mechanisms/ Pathophysiology
8.30-8.50
Keynote Lecture:Biomechanics in glaucoma
C. F. Burgoyne (USA)
8.50-10.00
Main session
The question of IOP Chairs: A. Hommer, F. Topouzis
- IOP: what is more important? Mean IOP, peak IOP, area under the curve, or fluctuation?
J. Caprioli (USA) - Should perfusion pressure replace IOP in monitoring glaucoma?
G. Marchini (Italy) - Focusing on glaucoma beyond IOP. Update and perspectives in:
- Genetics - A. C. Viswanathan (United Kingdom)
- Neuroprotection - N. Gupta (Canada)
- Ocular Blood Flow - J. Flammer (Switzerland)
Break
10.30-10.50
Keynote Lecture:IOP in focus R. N. Weinreb (USA)
10.50-11.30
Main Session: Intraocular pressure measurement
Chairs: F. Grehn (Germany), C. O’ Brien (Ireland)
- Is Goldmann applanation tonometry (GAT) still the gold standard for IOP measuring?
M. Iester (Italy) - Should we adjust Goldmann applanation tonometry (GAT) values based on central corneal thickness (CCT)? (Pros and cons)
J. D. Brandt (USA) - The place of dynamic contour tonometry (DCT), pneumotonometry and rebound tonometry
A. Kotecha (United Kingdom) - Challenges of 24 hrs monitoring (profiles) and continuous IOP measurement (debate)
A.G.P. Konstas (Greece), L.E. Pillunat (Germany), R.N. Weinreb(USA)
11.30-12.30
FREE PAPERS 4 (selected from the abstracts)
NEW IDEAS SESSION - MEDICAL AND SURGICAL TREATMENT
Chairs: A. Anton Lopez (Spain) A. Carassa (Italy) G. K. Krieglstein (Germany)
- FP4.1
The comparison of the effects of a local TNF alpha inhibitor, 5 flourouracil, and mitomycine C ON conjunctiva and tenon fibroblastic activity during wound healing period of rabbit eyes
O. Ocakoglu, D. Ucar, S. Solakoglu (Turkey) - FP4.2
Variation of surface topographies of glaucoma drainage devices as a factor of human tenon fibroblast adhesion
H. Thieme, L. Choritz, N. Pfeiffer (Germany) - FP4.3
Change in corneal endothelial cell density after Ahmed glaucoma valve implantation and trabeculectomy with mitomycin-C
C. Kim, E. Lee, K. Shin, S. Hyung (Korea) - FP4.4
Risk of loss of central vision following glaucoma filtration surgery in eyes with split fixation
S. Balekudaru, N. Choudhri, R. George, V. Lingam (India) - FP4.5
Co2 laser assisted deep sclerectomy (LADS) in glaucoma patients
S. Melamed, M. Goldenfeld, D. Kotlear, A. Skaat, E. Assia (Israel)
Allergan Lunch Symposium: Optimal Glaucoma Management in 2010
Chairs: A. Heijl (Sweden), A. Bron (France)
- Living with Glaucoma – What Matters for the Patients?
A. C. Viswanathan (United Kingdom) - Identifying fast progressors in glaucoma
B. Chauhan (Canada) - Rate of Progression and Decision Making
A. Heijl (Sweden) - Optimal Glaucoma Management, Right from the Start
A. Bron (France) - Management of the Progressing Patient – What is the Optimal Solution?
F. J. Goni (Spain) - Panel Discussion – Optimal Glaucoma Management:
A. Heijl (Sweden), L. M. Rossetti (Italy), F. J. Goni (Spain), A. G. Boehm (Germany), A. Bron (France)
14.15-15.15
INSTRUCTIONAL COURSES - 3 (8 parallel)
Room 1 - Unesco
C3 - 50 Angle closure (advanced)
J. Thygesen (Denmark), G. Gazzard (United Kingdom) T. Wong (Singapore)
Room 2
C3 - 3 Vascular aspects of glaucoma (basic/int)
I. Stalmans (Belgium), S. Orgül (Switzerland), G. Michelson (Germany), K. Gugleta (Switzerland), L. Schmetterer (Austria)
Room 7
C3 - 34 IOP: a scientific look at the ups and downs (intermediate)
L.E. Pillunat (Germany), A.G.P. Konstas (Greece)
Room 8
C3 - 28 + 29a Neuroprotection (basic/int)
S. Gandolfi (Italy), K. Martin (United Kingdom), L. Schmetterer (Austria)
Room 9
C3 - 39 Interpretation of visual fields (basic/int)
C. Vass (Austria), K. Rigal (Austria)
Room 9bis
C3 - 45 HRT in daily practice (intermediate)
T. Zeyen (Belgium), B. Chauhan (Canada), R. Burk (Germany)
Room Goya
C3 - 1 Glaucoma physiology and pathophysiology (basic/int)
T. Shaarawy (Switzerland), F. Grehn (Germany) , F.J. Goñi (Spain)
Room Privados
C3 – 63 Glaucoma Care in Developing Countries
K. Singh (USA), S. Melamed (Israel)
15.15-15.45
POSTER SESSION AT THE POSTER SITES
Glaucoma Progression – Imaging – Visual Field
15.45-16.45
INSTRUCTIONAL COURSES - 4 (8 parallel)
Room 1 - Unesco
C4 - 40 Identifying glaucomatous visual field progression in clinical practice (basic/int)
F.J. Goñi (Spain), A. Anton Lopez (Spain), N.M. Jansonius (The Netherlands)
Room 2
C4 - 4 Medical glaucoma treatment-promises and facts (basic)
G.K. Krieglstein (Germany), C. Faschinger (Austria)
Room 7
C4 - 42 Disc photographs for diagnosis (int/advanced)
J. Morgan (United Kingdom), H.G. Lemij (The Netherlands)
Room 8
C4 - 28 + 29b Neuroprotection (basic/int)
S. Gandolfi (Italy), K. Martin (United Kingdom), L. Schmetterer (Austria)
Room 9
C4 - 59 Genetics of POAG (advanced)
F. Topouzis (Greece), F. Grus (Germany), P. Founti (Greece), A.C. Viswanathan (United Kingdom)
Room 9bis
C4 - 47 Secondary glaucomas (basic/int)
J.F. Salmon (United Kingdom)
Room Goya
C4 - 14 Bleb care after filtrating surgery (Int.)
C.E. Traverso (Italy), F. Grehn (Germany)
Room Privados
C4 - 55 Health economics in glaucoma care (basic/int)
A. Azuara-Blanco (United Kingdom), A. Tuulonen (Finland), A. King (United Kingdom), J.Schouten (The Netherlands)
17.00-18.30
Alcon Afternoon Symposium
Chairs: F. Topouzis (Greece), R.N. Weinreb (USA)
- Co-Morbidities in Glaucoma - Typical Problems for the Patient
J. M. Benitez del Castillo (Spain) - Preserving the Normal Ocular Surface: The Alternatives
M. Rolando (TBA) - Optimizing 24h-IOP Control
A.G.P. Konstas (Greece) - Exciting & Different: New Medical Options for Glaucoma Treatment
G. J. Katz (USA) - The Alternative to BAK: Comparative Toxicity Profiles
C. Baudouin (France)
September 15th, 2010 - Wednesday
Auditorium
GLAUCOMA PROGRESSION
8.30-8.50
Keynote Lecture:Monitoring glaucoma progression: structure, function or both?
B. Chauhan (Canada)
8.50-10.00
Main Session: Glaucoma progression Chairs: F.J. Goñi (Spain), T. Zeyen (Belgium)
- How imaging data should be used in the clinical management of progression?
D. Garway-Heath (United Kingdom) - How much visual field data do we need to measure progression?
L. M. Rossetti (Italy) - Making therapeutic decisions; Linking target IOP and visual field progression
F.J. Goñi (Spain) - Ocular hypertension; to treat or not to treat? OHTS 2
R. Parrish (USA) - Panel discussion
Break
10.30-11.40
Main Session: Unmet needs in glaucoma management. A global perspective (Joint EGS / LAGS Symposium)
Chairs: C. Migdal (United Kingdom), R.A. Hitchings (United Kingdom), R. Susanna (Brazil)
- New therapeutic end-points
F. Cordeiro (United Kingdom) - Integrating structure and function
I. Stalmans (Belgium) - Phenotyping/ genotyping
F. Topouzis (Greece) - Case-finding in glaucoma
R. A. Pérez-Grossman (Peru) - Neuroprotection
K. Martin (United Kingdom) - New glaucoma surgical procedures
D. Grigera (Argentina)
11.40-12.20
FREE PAPERS 3 (selected from the abstracts)
GLAUCOMA PROGRESSION - IMAGING – VISUAL FIELD
Chairs: A. Heijl (Sweden) T. Zeyen (Belgium)
- FP3.1
The adherence rate influences the visual field progression
G.C.M. Rossi, G.M. Pasinetti, L. Scudeller, P.E. Bianchi (Italy) - FP3.2
In vivo morphometry of the lamina cribrosa pore using adaptive optics scanning laser ophthalmoscopy
T. Akagi, M. Hangai, K. Takayama, A. Nonaka, S. Ooto, N. Yoshimura (Japan) - FP3.3
Comparison of retinal nerve fiber layer measurement with three different optical coherence tomography devices
A. Bron, F. Nicot, A. Bonnabel, S. Aho, C. Creuzot Garcher (France) - FP3.4
Effect of signal strength on reproducibility of peripapillary retinal nerve fiber layer thickness measurement and its classification by cirrus optical coherence tomography
J.H. Kim, N.R. Kim, E.S. Lee, C.Y. Kim, K.T. Ma (Korea) - FP3.5
Optic disc evaluation in optic neuropathies: The Optic Disc Assessment Project (The ODAP Project)
E. O'Neill, G. Kong, D.A. Mackey, A. Hewitt, M. Coote, H.V. Danesh-Meyer, J.G. Crowston (Australia, New Zealand)
Merck Sharp & Dohme Lunch-Symposium: Optimizing Strategies in the Clinical Management of Glaucoma
Chair: C.E. Traverso (Italy)
- Welcome & Opening Remarks
C.E. Traverso (Italy) - The Role of Ocular Surface Disease in Glaucoma Management
C. Baudouin (France) - A Novel Glaucoma Therapy: The Pharmacology and Clinical Profile of Tafluprost
N. Pfeiffer (Germany) - New Clinical Evidence on 24-Hour IOP Management
A.G.P. Konstas (Greece) - Predictors of Visual Field Progression
A. Martinez (Spain) - Questions and Closing Remarks
C.E. Traverso (Italy)
INSTRUCTIONAL COURSES - 5 (8 parallel)
Room 1 - Unesco
C5 - 5 + 6a Medical management of POAG / EGS flow charts (basic/int)
J. Thygesen (Denmark), A. Hommer (Austria)
Room 2
C5 - 12 Trabeculectomy: the end of the surgery, the beginning of the intervention (int/advanced)
I. Stalmans (Belgium), T. Zeyen (Belgium), A. Bron (France)
Room 7
C5 - 17 Current approaches to surgery of angle closure glaucoma (int/advanced)
A. Azuara-Blanco (United Kingdom), P. Chew (Singapore) G. Gazzard (United Kingdom)
Room 9
C5 - 35 Modern developments in tonometry (int/advanced)
A.G. Boehm (Germany)
Room 9bis
C5 - 61 Retina success, glaucoma stress! (intermediate)
L.E. Sararols Ramsay (Spain), A. Mannelli (Spain)
Room Goya
C5 - 36 Target pressure and target function in long-term glaucoma management (intermediate)
K. Singh (USA), P. Denis (France)
Room Privados
C5 - 31 Rates of progression in glaucoma (basic/int)
B. Chauhan (Canada), A. Heijl (Sweden)
Room 8
C5 – 15a Glaucoma surgery: postoperative complications and management (int/advanced)
C.E. Traverso (Italy), M. Nardi (Italy), K. Barton (United Kingdom)
15.15-15.45
POSTER SESSION AT THE POSTER SITES
Medical and Surgical Treatment
15.45-16.45
INSTRUCTIONAL COURSES - 6 (8 parallel)
Room 1 - Unesco
C6 - 5 + 6b Medical management of POAG / EGS flow charts (basic/int)
J. Thygesen (Denmark), A. Hommer (Austria)
Room 2
C6 - 11 Safe trabeculectomy (advanced)
T. Zeyen (Belgium), P.T. Khaw (United Kingdom)
Room 7
C6 - 56 Prevalence / incidence of glaucoma (basic/int)
F. Topouzis (Greece), A. Tuulonen (Finland)
Room 8
C6 – 15b Glaucoma surgery: postoperative complications and management (int/advanced)
C.E. Traverso (Italy), M. Nardi (Italy), K. Barton (United Kingdom)
Room 9
C6 - 57 Methods to design, conduct and analyze RCTs (advanced)
L. M. Rossetti (Italy), P. Denis (France)
Room 9bis
C6 - 52 Pigment dispersion syndrome (basic)
S. Gandolfi (Italy) , J.F. Salmon (United Kingdom)
Room Goya
C5 - 23 Non penetrating glaucoma surgery (basic)
T. Shaarawy (Switzerland), Y. Lachkar (France)
Room Privados
C6 - 16 Surgery at the slit lamp (Int.)
A. Mannelli (Spain), F.J. Goñi (Spain)
September 16th, 2010 - Thursday
Auditorium
MEDICAL AND SURGICAL TREATMENT
8.30-8.50
Keynote Lecture:The real world - Glaucoma and ocular comorbidity
J. Crowston (Australia)
8.50-10.00
Round Table
Chairs: R. A. Hitchings (United Kingdom), G. K. Krieglstein(Germany)
Topical issues in glaucoma management
- Is compliance a barrier?
G. K. Krieglstein (Germany) - Switching, adding and defining maximum medical treatment
C.E. Traverso (Italy) - Where does combination therapy fit in?
J. Thygesen (Denmark) - New delivery systems; now and in the future
M. Diestelhorst (Germany) - Preservative-free medications: limited use vs extended use
C. Baudouin (France) - Electronic records - are they suitable in glaucoma?
M. Schargus (Germany)
10.00-10.30
Break
10.30-11.40
Main Session: Glaucoma surgery, the cutting edge
Chairs: P.T. Khaw (United Kingdom), C.E. Traverso (Italy)
- How to evaluate surgical techniques (Laser, NPGS, new devices)?
T. Shaarawy (Switzerland) - Optimizing trabeculectomy outcome
P.T. Khaw (United Kingdom) - Gonioscopy and angle imaging as a tool for deciding on surgery
Y. Lachkar (France) - Trabeculectomy vs glaucoma implants as an initial surgical treatment
K. Barton (United Kingdom) - New directions in paediatric glaucoma surgery (360o trabeculotomy, trabectome, Laser goniotomy, other concepts)
J. L. Brookes (United Kingdom) - Cataract surgery for angle closure
A. Azuara-Blanco (United Kingdom)
11.40-12.20
FREE PAPERS 1 (selected from the abstracts)
EPIDEMIOLOGY - HEALTH ECONOMICS - QUALITY OF LIFE
Chairs: A. Azuara Blanco (United Kingdom) A. Tuulonen (Finland)
- FP1.1
Trends in the rate of trabeculectomy
A. Tatham, U. Sarodia (UK)/li> - FP1.2
Similarities and differences in risk factors for primary open-angle glaucoma and pseudoexfoliative glaucoma in the Thessaloniki Eye Study
F. Topouzis, M.R. Wilson, A. Harris, E. Anastasopoulos, F. Yu, T. Pappas, P. Founti, A. Koskosas, A. Salonikiou, A.L. Coleman (Greece, USA) - FP1.3
Quality of life in ocular hypertension and primary open-angle glaucoma
C. Wolfram, K. Lorenz, H. Waltrich, R. Shlaen, Y. Verboven, N. Pfeiffer (Germany, Belgium) - FP1.4
How much field must a glaucomatous patient loose before being aware of a visual disability?
N. Ungaro, M.G. Tardini, G. Bacchi, F. Giacosa, S.A. Gandolfi (Italy) - FP1.5
Which glaucoma patients are safe drivers? Predictive value of UFOV, Esterman and integrated visual field
E. Leloup, A.M. Stevens, D. De Bacquer, M. Tant, Ph. Kestelyn, T. Zeyen (Belgium)
Lunch
14.15-15.15
INSTRUCTIONAL COURSES - 7 (8 parallel)
Room 1 - Unesco
C7 - 9 + 10a Glaucoma surgery (advanced)
F. Grehn (Germany), P.T. Khaw (United Kingdom)
Room 2
C7 - 49 Exfoliation (basic/int)
A.G.P. Konstas (Greece), G. Hollo (Hungary), M. Teus (Spain)
Room 7
C7 - 7 Laser procedures in glaucoma (basic/int)
J. Thygesen (Denmark), A. Bagnis (Italy)
Room 8
C7 - 25 + 26a Innovation in paediatric glaucoma surgery (advanced)
M. Papadopoulos (United Kingdom), J. L. Brookes (United Kingdom), J. Garcia Feijoo (Spain)
Room 9
C7 - 27 Refractive surgery in the glaucoma patient (basic/int)
S. Kaminski (Austria), L.E. Pillunat (Germany)
Room 9bis
C7 - 43 Anterior segment imaging technology (intermediate)
I. Stalmans (Belgium), M. Papadia (Italy)
Room Goya
C7 - 33 Gonioscopy in the glaucoma patient (basic/int)
A. Hommer (Austria), C. Faschinger (Austria), T. Zeyen (Belgium)
Room Privados
C7 - 51 Secondary Glaucomas (intermediate)
S. Gandolfi (Italy), K. Barton (United Kingdom)
15.15-15.45
POSTER SESSION AT THE POSTER SITES
IOP – Biomechanincs – Genetics – Neuroprotection – Blood Flow
15.45-16.45
INSTRUCTIONAL COURSES - 8 (8 parallel)
Room 1 - Unesco
C8 - 9 + 10b Glaucoma surgery (advanced)
F. Grehn (Germany), P.T. Khaw (United Kingdom)
Room 2
C8 - 44 Posterior segment imaging technology (basic/int)
H.G. Lemij (The Netherlands), D. Garway-Heath (United Kingdom), M. Iester (Italy)
Room 7
C8 - 30 Neuroprotection (advanced)
F. Cordeiro (United Kingdom), N. Gupta (Canada), L. Levin (United Kingdom)
Room 8
C8 - 25 + 26b Innovation in paediatric glaucoma surgery (advanced)
M. Papadopoulos (United Kingdom), J. L. Brookes (United Kingdom), J. Garcia Feijoo (Spain)
Room 9
C8 - 62 Bloodflow and glaucoma therapy (basic/int)
J. Flammer (Switzerland)
Room 9bis
C8 - 41 Using peridata (basic)
T. Zeyen (Belgium), J. Weber (Germany)
Room Privados
C8 - 24 Non penetrating glaucoma surgery (advanced)
T. Shaarawy (Switzerland), Y. Lachkar (France)
Room Goya
C8 - 21 Baerveldt tube implantations. Challenging cases (advanced)
K. Barton (United Kingdom)
September 17th, 2010 - Friday
8.30-14.00 SPANISH DAY
Room 1 - Unesco
- Welcome
F.M. Honrubia Lopez (Spain) - 8.30-9.00
Introduction
Chairman: R. Susanna (Brazil)
Is there any systematic and orderly manner to examine the glaucoma patient?
R. Susanna (Brazil)
ABC in glaucoma genetics
E. Milla (Spain)
How to measure QoL in glaucoma
V. Polo (Spain) - 9.00-9.45
Minisymposium I - Intraocular pressure reading and interpretation of results
Chairman: I. Vinuesa (Spain)
Importance of IOP in glaucoma management
J. L. Urcelay (Spain)
Non-corneal error sources
J.A. Dias (Portugal)
Alternatives to GAT
A. Martinez Compadre (Spain)
Biomechanical properties of the cornea and error sources
K. Schargel-Palacios (Spain) - 9.45-10.30
Gonioscopy. Tips that do the trick (Workshop on gonioscopy)
E. Arranz- Marquez (Spain)
M.A. Teus (Spain)
Room Goya
-
9.00-10.30
Minisymposium I - Glaucoma walls and doors
Chairman: A. Mannelli (Spain)
The corneal wall: thickness and beyond
CCT: what means in clinical practice
J. Belda Sanchis (Spain)
Viscoelasticity
J. Moreno (Spain)
New tonometers: how to interpret IOP values?
J. M. Martinez de la Casa (Spain)
The angle door: functionality
From macro-to-micro anatomy
M.P. Villegas-Pérez (Spain)
Trabecular meshwork cells and their functions
M.D. Pinazo Durán (Spain)
Drugs and targets: where are we now?
F.J. Muñoz Negrete (Spain)
The laminar wall and behind
Translaminar pressure
A. Martinez (Spain)
Vascular supply
J.M. Ramírez Sebastián (Spain)
Histopathological changes at short and long term
A. Triviño Casado (Spain)
The suprachoroidal door: a therapeutic option?
Pharmacology
P.C. Fernández-Vila (Spain)
Surgery
L. Pablo Júlvez (Spain)
Room 1 - Unesco
-
11.00-11.45
Minisymposium II - Visual field interpretation
Chairman: H. Fontana (Argentina)
Top ten points to interpret a Humphrey visual field
F. Ussa-Herrera (Spain)
Top ten points to interpret an Octopus visual field
C. Larena (Spain)
Artefacts
P. Faria (Portugal)
New programs for progression: what do they add?
A. Ferreras (Spain) -
11.45-12.30
Optic disc and retinal nerve fibre layer examination. False and true, positive and negative findings
Chairman: I. Maynart (Brazil)
Structural tests: error sources - GDx- HRT- OCT
J. M. Larrosa (Spain), V. Polo (Spain)
Room Goya
-
11.00-12.00
Minisymposium II - Imaging and progression
Chairman: D. Grigera (Argentina)
I prefer events
A. Gil Ibarra (Spain)
I prefer trends
J. Bardavío (Spain)
Short Discussion
Progression algorithms for GDx
J. Benítez del Castillo (Spain)
Progression algorithms for HRT III
J.M. Larrosa (Spain)
Progression algorithms for OCT (spectral domain)
A. Antón Lopez (Spain) -
12.00-12.30
Visual Fields: making objective the subjective
A new algorithm to detect progression
M.A. González de la Rosa (Spain)
Progression algorithms for HFA
J.L. Hernández Barahona (Spain)
Discussion -
12.30-14.00
Treatment options
Chairman: J. F. Casiraghi (Argentina)
First line medical treatment: monotherapy or fixed combinations? EGS guidelines
M. Canut (Spain)
Patient profile and treatment choice
A. Figueiredo (Portugal)
Debate: Why I still do/don't perform laser trabeculoplasty? Would I be "selective" or "classic"?
J. González (Spain,) C. Méndez Hernandez (Spain,) J. Benítez del Castillo (Spain)
Long-term results in glaucoma surgery: do the different techniques provide different results?
Anti VEGF in Glaucoma treatment
Anti VEGF Role in the Management of Neovascular Glaucoma.
A. Coelho (Portugal)
Antiangiogenic therapy in glaucoma treatment. Filtrating surgery.
G. Rebolleda (Spain)
Drainage implants.
F. Gil Carrasco (Mexico) - 14.00
CLOSING REMARKS
J. García Sánchez (Spain)
8.30-12.00 SIGs – SPECIAL INTEREST GROUP MEETINGS
8.30-9.30
-
Room 7
SIG Ocular Blood Flow
Chair: I. Stalmans (Belgium)
8.30 - 8.35
Welcome - Ingeborg Stalmans (Belgium)
8.35 - 8.45
EGS booklet on Ocular Blood Flow - Leopold Schmetterer (Austria)
8.45 - 9.10
Reports on OBF measuring techniques:
- Retinal Vessel Analyzer - Selim Orgül (Switzerland)
- Color Doppler Imaging - Ingeborg Stalmans (Belgium)
- Laser Doppler Flowmetry - Charles Riva (Switzerland)
- Laser Speckle Flowgraphy - Leopold Schmetterer (Austria)
9.10-9.30
Future perspective: Multicenter CDI Standardization project
Selim Orgül (Switzerland), Ingeborg Stalmans (Belgium), Leopold Schmetterer (Austria), Charles Riva (Switzerland) -
Room 2
SIG Glaucocard
Chair: M. Schargus (Germany)
Development of Glaucocard since last EGS SIG 2008
Brief overview of technical development
Presentation of Glaucocard Starter Package
Demonstration of web interface of Glaucocard
Demonstration of data transfer to Glaucocard
Next steps in development
Discussion
- Room 9bis
SIG Health Economics “Think Thank”
Chair: A. Tuulonen (Finland)
8.30 -8.40
Welcome and introduction – A. Tuulonen (Finland)
- Summary of activities to date
- Goals of this Think tank
- Goals for future collaboration? To be discussed at the end
- The next meeting in September 2-4, Malmo?
8.40 – 10.30
Detailed description and discussion
A discrete event model to study effects and costs of different patient management strategies for ocular hypertension and glaucoma
Introduction
Jan Schouten (The Netherlands)
Development and validation of the model
A. van Gestel (The Netherlands)
How to summarize the scientific literature
C. Webers (The Netherlands)
Cost-effectiveness of OH and POAG treatment
C. Webers (The Netherlands)
Management strategies for Ocular hypertension
H. Beckers (The Netherlands)
Management strategies for POAG
J. Schouten (The Netherlands)
Other uses and future research with this model
J. Schouten (The Netherlands)
9.45 - 10.15
Discussion
10.15 - 10.30
Coffee break
10.30 - 12.00
Presentations of the projects
10.30 - 11.25
Review of glaucoma projects, their approaches and challenges
L. Vale, professor of health economics, Aberdeen (United Kingdom)
11.25 - 11.55
Electronic monitoring of compliance
M. Diestelhorst
Costs of glaucoma care in Switzerland - facts and problems
F. Meier- Gibbons (Switzerland)
11.55 - 12.15
Evaluation of the think tank and future plans
A. Azuara-Blanco (United Kingdom), A. Tuulonen (Finland)
break
9.45-10.45
-
Room 7
SIG Paediatric Glaucoma
Chair: F. Grehn (Germany)
New approaches in paediatric glaucoma surgery
how far can trabeculotomy be modified or improved
Improvements of goniotomy – is there a role for excimer laser, trabectome or others
The experience of the Madrid National Reference Center for paediatric glaucoma (t.b.d.)
Is there a need for a multinational multicenter treatment study on congenital glaucoma?
The big problem: Aphakic paediatric glaucoma - Room 8
SIG Neuroprotection:
Chair: F. Cordeiro (United Kingdom)
break
11.00-12.00
-
Room 2
SIG Glaucogene
Chair: F. Topouzis (Greece)
11.00 – 11.15
Update on the EGS GlaucoGENE Project - Panayiota Founti (Greece)
11.15 – 11.30
EGS GlaucoGENE Feasibility Study Overview - Panayiota Founti (Greece)
11.30 – 11.45
Immunoproteomics - Franz Grus (Germany)
11.45 – 12.00
Discussion
-
Room 7
SIG Exfoliation Glaucoma
Chair: G. Hollo (Hungary), A.G.P. Konstas (Greece)
Welcome
G. Hollo (Hungary), A.G.P. Konstas (Greece)
Short research presentations
Discussion
Summary
A.G.P. Konstas (Greece), G. Hollo (Hungary) - Room 8
SIG Angle Closure
Chair: G. Gazzard (United Kingdom)